Recent news on Mometasone Furoate

Schering-Plough announces European approval of new formulations of ...  -  May 1, 2007
News-Medical.net,...efforts include the CLARITIN (loratadine) family of nonsedating antihistamines and NASONEX (mometasone furoate monohydrate) Nasal Spray, 50 mcg.

Schering-Plough Announces EU Approval of Two New Formulations of ...  -  Apr 26, 2007
Earthtimes.org...efforts includethe CLARITIN(R) (loratadine) family of nonsedating antihistamines and NASONEX(R) (mometasone furoate monohydrate) Nasal Spray, 50 mcg.

Steroid Nasal Sprays Relieve Sinusitis Symptoms  -  Apr 24, 2007
eMaxHealth.com,Intranasal corticosteroids used included fluticasone propionate (Flonase), mometasone furoate (Nasonex) and budesonide (Rhinocort).

Ocular Allergic Rhinitis Symptoms Respond to Mometasone Nasal ...  -  Mar 5, 2007
DG News...[Presentation title: Ocular Symptoms of Seasonal Allergic Rhinitis Can Be Treated Effectively With an Inhaled Corticosteroid (Mometasone Furoate Nasal

Market Report -- In Play ()  -  Feb 26, 2007
MSN MoneyIn addition, a group of patients treated with intranasal Nasonex (SGP) (mometasone furoate monohydrate) did not show symptom improvement compared to placebo

NASONEX(R) Earns the Arthritis Foundation Ease-of-Use Commendation  -  Feb 28, 2007
PR Newswire (press release),The NASONEX(R) (mometasone furoate monohydrate) Nasal Spray 50mcg* delivery device is the first nasal allergy spray acknowledged by the Arthritis Foundation

NASONEX(R) Earns the Arthritis Foundation Ease-of-Use Commendation  -  Mar 12, 2007
Drug Newswire (press release),28 /PRNewswire-FirstCall/ -- Schering-Plough today announced that the device used to deliver NASONEX(R) (mometasone furoate monohydrate) nasal spray for the

Nasonex earns the Arthritis Foundation ease-of-use commendation  -  Mar 5, 2007
SpiritIndia,Schering-Plough announced that the device used to deliver NASONEX(R) (mometasone furoate monohydrate) nasal spray for the treatment of nasal allergy

Nasonex Earns the Arthritis Foundation Ease-of-Use Commendation  -  Feb 28, 2007
PharmaLive.com (press release),KENILWORTH, NJ, February 28, 2007 /PRNewswire-FirstCall/ -- Schering-Plough today announced that the device used to deliver NASONEX(R) (mometasone furoate

Steroid-Free Astelin(R) Nasal Spray (R) Demonstrated Seasonal ...  -  25 Feb 2007
PR Newswire (press release),In addition, a group of patients treated with intranasal Nasonex(R) (mometasone furoate monohydrate) did not show symptom improvement compared to placebo

Schering-Plough's turnaround is moving on apace  -  Jan 30, 2007
Pharma Times (subscription),...helped by expanded indications, while Nasonex (mometasone furoate) for allergies brought in $253 million, up 37%. Brain cancer treatment Temodar enjoyed

Schering-Plough Cites Today's Anacor Agreement as Latest in Series ...  -  Feb 2, 2007
PR Newswire (press release),Schering-Plough's once daily inhaled corticosteroid mometasone, the active ingredient in ASMANEX (mometasone furoate) and Novartis' once daily beta2-agonist

Schering-Plough parades its partnership credentials  -  Feb 5, 2007
Pharma Times (subscription),The inhaled product would combine SP's inhaled steroid Asmanex (mometasone furoate) with a novel beta agonist, indacaterol (QAB149), developed by Novartis.

Nasonex (Mometasone Furoate Monohydrate) Approved by Health Canada ...  -  Dec 5, 2006
DG NewsPOINTE-CLAIRE, QC, CANADA -- December 6, 2006 -- Schering Canada announced that Nasonex® (mometasone furoate monohydrate) has been approved by Health Canada ...

International Approvals: Solaraze, Nasonex, Advate  -  Dec 5, 2006
Medscape (subscription)...approved diclofenac sodium 3% gel for the management of actinic keratosis; Health Canada has approved a new indication for mometasone furoate monohydrate nasal ...

New Data Show Incidence of Drowsiness and Sedation is Higher for ...  -  Nov 30, 2006
Earthtimes.org...the company's research effortsinclude the CLARITIN(R) (loratadine) family of nonsedating antihistamines andNASONEX(R) (mometasone furoate monohydrate) Nasal ...

KENILWORTH, New Jersey, November 29 /PRNewswire/ --  -  Nov 30, 2006
netPR.pl (komunikaty prasowe),...the company's research efforts include the CLARITIN(R) (loratadine) family of nonsedating antihistamines and NASONEX(R) (mometasone furoate monohydrate) Nasal ...

Scent-Free Nasonex(R) (Mometasone Furoate Monohydrate) Now ...  Oct 20, 2006
POINTE-CLAIRE, QUEBEC, CANADA -- October 20, 2006 -- Nasonex® (mometasone furoate monohydrate), the number one doctor-prescribed nasal spray in Canada for the ... -DG News Nasonex (Mometasone Furoate Monohydrate) Approved by Health Canada ...  -  12 Dec 2006
DG NewsPOINTE-CLAIRE, QC, CANADA -- December 6, 2006 -- Schering Canada announced that Nasonex® (mometasone furoate monohydrate) has been approved by Health Canada

International Approvals: Solaraze, Nasonex, Advate  -  Dec 5, 2006
Medscape (subscription)On November 24, Health Canada approved a new indication for mometasone furoate monohydrate nasal spray (Nasonex, made by Schering Canada, Inc), allowing its

Mometasone Equivalent to Fluticasone in Patients with Moderate to ...  -  Nov 15, 2006
DG News...[Presentation title: Comparative Trial of Mometasone Furoate Versus Fluticasone Propionate in Patients With Moderate to Severe Persistent Asthma.

New Data Show Incidence of Drowsiness and Sedation is Higher for ...  -  Nov 30, 2006
Drug Newswire (press release),...efforts include the CLARITIN(R) (loratadine) family of nonsedating antihistamines and NASONEX(R) (mometasone furoate monohydrate) Nasal Spray, 50 mcg.

New Data Show Incidence of Drowsiness and Sedation is Higher for ...  -  Nov 30, 2006
Earthtimes.org...effortsinclude the CLARITIN(R) (loratadine) family of nonsedating antihistamines andNASONEX(R) (mometasone furoate monohydrate) Nasal Spray, 50 mcg.(i)

Schering-Plough Announces Global Agreement With Novartis to ...  Aug 13, 2006
ASMANEX(R) TWISTHALER(R) 220 mcg (mometasone furoate inhalation powder) is for the maintenance treatment of asthma for patients 12 years of age and older. ... -Finanzen.net

Novartis, Schering-Plough link up for once-daily asthma combo  Aug 14, 2006
The inhaled product would combine Schering-Plough's inhaled steroid Asmanex (mometasone furoate) with a novel beta agonist, indacaterol (QAB149), developed by ... -Pharma Times (subscription)

SCHERING-PLOUGH APPOINTS HERB EHRENTHAL GROUP VICE PRESIDENT ...  Jul 11, 2006
Under his leadership, he and his team have received awards for the VYTORIN and NASONEX® (mometasone furoate monohydrate) ad campaigns. ... -Business New Jersey (subscription)

Schering-Plough to Expand Its Presence in Latin America ...  Jun 21, 2006
ZETIA(R) (ezetimibe), ZETSIM(R) (ezetimibe/simvastatin), CLARITIN(R) (loratadine), CLARINEX(R) (desloratadine) and NASONEX(R) (mometasone furoate monohydrate). ... -Finanzen.net



Are You Allergic to Your Town?  Apr 18, 2006
...makers of Febreze Allergen Reducer(R) Fabric Refresher and Swiffer(R) Dusters, Schering-Plough, makers of Nasonex(R) (mometasone furoate monohydrate) Nasal ... - PR Newswire





Taro Receives Final Approval for Mometasone Furoate Topical ...  Mar 15, 2006
...final approval from the US Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Mometasone Furoate Topical Solution USP ... - Genetic Engineering News

Taro Pharma Gets Final FDA Approval For Mometasone Furoate Topical ...  Mar 15, 2006
Taro Pharmaceuticals USA Inc., has received final approval from the FDA for its Abbreviated New Drug Application for Mometasone Furoate Topical Solution USP ... - Trading Markets

Taro Pharma's ANDA For Mometasone Furoate Lotion Gets Final FDA ...  Mar 15, 2006
...received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application or ANDA for Mometasone Furoate Topical Solution USP ... - Trading Markets

FDA approves Taro skin treatment  Mar 16, 2006
December 2004. Taro USA also has ANDA approvals for Mometasone Furoate Ointment USP, 0.1% and Mometasone Furoate Cream USP, 0.1%. Taro ... - Globes

Taro OK'd for generic of Schering topical  Mar 15, 2006
The company said the Food and Drug Administration has given approval to its mometasone furoate topical solution, 0.1 percent lotion for the temporary relief of ... - United Press International



Schering-Plough swings to profit in Q4  Jan 31, 2006
Crohn's disease and arthritis drug Remicade (infliximab), which jumped 19% to $251 million; the allergy drug Nasonex (mometasone furoate monohydrate), after a ... - Pharma Times (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional